Skip to main content

Eton Pharmaceuticals, Inc.

ETON
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001710340

In the last 90 days, Eton Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 5 sales; 164 institutions reported holding it in 13F filings for Q2 2026, worth $722.6M in total; no superinvestor holds it.

13F holders, Q2 2022

Institutional positions in Eton Pharmaceuticals, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
29
−1 vs. Q1 2022
Shares held
5.92M
+154.7K (+2.7%) vs. Q1 2022
Total value
$14.6M
−$12.7M (−46.5%) vs. Q1 2022
New holders
4
5 more added
Sold out
5
10 more reduced

1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ETON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 29 institutions
Q1 2021: 50 institutionsQ2 2021: 46 institutionsQ3 2021: 37 institutionsQ4 2021: 32 institutionsQ1 2022: 31 institutionsQ2 2022: 29 institutionsQ3 2022: 32 institutionsQ4 2022: 31 institutionsQ1 2023: 35 institutionsQ2 2023: 33 institutionsQ3 2023: 50 institutionsQ4 2023: 56 institutionsQ1 2024: 44 institutionsQ2 2024: 45 institutionsQ3 2024: 48 institutionsQ4 2024: 71 institutionsQ1 2025: 86 institutionsQ2 2025: 87 institutionsQ3 2025: 103 institutionsQ4 2025: 104 institutionsQ1 2026: 116 institutionsQ2 2026: 164 institutions
Value heldQ2 2022: $14.6M
Q1 2021: $63.7MQ2 2021: $48.1MQ3 2021: $29.5MQ4 2021: $24.1MQ1 2022: $27.4MQ2 2022: $14.6MQ3 2022: $14.4MQ4 2022: $18.2MQ1 2023: $22.5MQ2 2023: $20.9MQ3 2023: $28.8MQ4 2023: $33.5MQ1 2024: $28.8MQ2 2024: $28.7MQ3 2024: $60.0MQ4 2024: $181.5MQ1 2025: $189.7MQ2 2025: $243.3MQ3 2025: $394.7MQ4 2025: $277.5MQ1 2026: $438.6MQ2 2026: $722.6M
Institutions holding ETON and their total value by quarter
QuarterHoldersValue
Q2 2026164$722.6M
Q1 2026116$438.6M
Q4 2025104$277.5M
Q3 2025103$394.7M
Q2 202587$243.3M
Q1 202586$189.7M
Q4 202471$181.5M
Q3 202448$60.0M
Q2 202445$28.7M
Q1 202444$28.8M
Q4 202356$33.5M
Q3 202350$28.8M
Q2 202333$20.9M
Q1 202335$22.5M
Q4 202231$18.2M
Q3 202232$14.4M
Q2 202229$14.6M
Q1 202231$27.4M
Q4 202132$24.1M
Q3 202137$29.5M
Q2 202146$48.1M
Q1 202150$63.7M

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding Eton Pharmaceuticals, Inc.; share changes are against Q1 2022.

Institutions holding ETON in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Opaleye Management Inc.2,462,500$6.45M2.91%+83,225+3.5%Added
Vanguard Group Inc872,871$2.29M0.00%00.0%Unchanged
AWM Investment Company, Inc.463,320$1.21M0.19%−9,268−2.0%Reduced
Roumell Asset Management, LLC449,438$1.18M2.29%00.0%Unchanged
BlackRock Inc.291,713$764.0K0.00%−4,826−1.6%Reduced
Bridgeway Capital Management, LLC266,462$698.0K0.02%+41,299+18.3%Added
Paradigm Capital Management Inc200,000$524.0K0.04%+100,000+100.0%Added
Geode Capital Management, LLC186,971$489.0K0.00%00.0%Unchanged
Bank of New York Mellon Corp78,872$207.0K0.00%−583−0.7%Reduced
State Street Corp77,903$204.0K0.00%−13,700−15.0%Reduced
Blair William & Co38,932$102.0K0.00%00.0%Unchanged
Northern Trust Corp30,355$80.0K0.00%00.0%Unchanged
Citadel Advisors LLC27,775$73.0K0.00%+27,775New
Virtu Financial LLC25,611$67.0K0.01%+25,611New
Chicago Trust Co NA16,700$44.0K0.01%00.0%Unchanged
PDT Partners, LLC15,355$40.0K0.00%−8,065−34.4%Reduced
Charles Schwab Investment Management Inc13,239$35.0K0.00%+13,239New
Quantum Private Wealth, LLC11,500$30.0K0.02%+11,500New
Financial Advisors Network, Inc.10,633$28.0K0.01%00.0%Unchanged
Morgan Stanley8,435$23.0K0.00%−19,636−70.0%Reduced
Group One Trading, L.P.7,809$20.0K0.00%−18,510−70.3%Reduced
JPMorgan Chase & Co4,125$11.0K0.00%−20,148−83.0%Reduced
Wells Fargo & Company4,138$11.0K0.00%−3,486−45.7%Reduced
UBS Group AG3,768$10.0K0.00%−787−17.3%Reduced
Tower Research Capital LLC (TRC)2,066$5.00K0.00%+728+54.4%Added
Plante Moran Financial Advisors, LLC1,000$3.00K0.00%00.0%Unchanged
BNP Paribas Arbitrage, SA350$9170.00%00.0%Unchanged
Lindbrook Capital, LLC4$00.00%00.0%Unchanged
Westside Investment Management, Inc.345,550––+103,330+42.7%Added
First Citizens Bank & Trust Co0$00.00%−100,000−100.0%Sold out
Gsa Capital Partners LLP0$00.00%−24,475−100.0%Sold out
Goldman Sachs Group Inc0$00.00%−17,610−100.0%Sold out
Belvedere Trading LLC0$00.00%−10,876−100.0%Sold out
Royal Bank of Canada0$00.00%−23−100.0%Sold out
Susquehanna Fundamental Investments, LLC––––Not filed